$72.55
Today
as of Jul 22, 09:05 ET
Last 30 days
Recent Press Releases & News
RBC Trims Price Target on Legence to $101 From $106, Keeps Outperform Rating
Are Options Traders Betting on a Big Move in Legence Stock?
Barclays Raises its Price Target on Legence (LGN)
Overview
52-week range
$27
$107
57% of range
Avg surprise (last 1)
+26.3%
Avg reaction (last 1)
-11.0%
0% positive
Latest IV / EM
108%
EM ±25.2% · $75 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu May 14, 2026 | Mar/2026 | $0.24 | $0.19 | +26.3% | — | -11.0% | earnings |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Aug 13, 2026 | Jun/2026 | OTHER | $0.26 | — |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|
| Revenue | $1.04B | — | $708M | $506M | — | $561M |
| Cost of revenue | $852M | — | $560M | $394M | — | $442M |
| Gross profit | $186M | — | $148M | $112M | — | $119M |
| Operating income | $22M | — | $37M | $17M | — | $27M |
| Net income | $16M | — | $-576,000 | $-21M | — | $-1M |
| EPS (diluted) | $0.13 | — | — | — | — | — |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $245M | $230M | $176M | — | $81M | — |
| Inventory | $14M | $11M | $11M | — | $10M | — |
| Total current assets | $1.47B | $1.11B | $1.04B | — | $756M | — |
| Total assets | $3.48B | $2.68B | $2.60B | — | $2.35B | — |
| Long-term debt | — | — | — | — | — | — |
| Total liabilities | $2.53B | $1.89B | $1.77B | — | $2.15B | — |
| Total equity | $505M | $392M | $388M | — | — | — |